Renal Replacement Therapy for Intoxications Timothy E. Bunchman Pediatric Nephrology & Transplantation DeVos Children’s Hospital Grand Rapids, MI (thanks.

Slides:



Advertisements
Similar presentations
RRT and Intoxications Timothy E Bunchman. Case Study-1 17 y/o female with poly pharmacy overdose including risperidone, stratttera and long acting Lithium.
Advertisements

TREATMENT OF INTOXICATIONS WITH CONTINUOUS RENAL REPLACEMENT THERAPY
IMPLEMENTATION & USE of CRRT in PEDIATRIC INTOXICATIONS Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Norma J Maxvold Pediatric Critical Care
Renal Replacement Therapy Options for Children
Acute Renal Replacement Therapy for the Infant Dr.Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School.
Pediatric CRRT: Terminology and Physiology
Hemodiafiltration and Hemofiltration
Definition Continuous Renal Replacement Therapy (CRRT)
CVVH vs CVVHD Does it Matter?
So how do I dose this drug “X” Timothy E Bunchman
Continuous Veno-venous Hemodiafiltration Therapy for Acute Decompensation with Cerebral Edema in Maple Syrup Urine Disease Joshua J. Zaritsky M.D., Julian.
DIALYSIS? HEMOPERFUSION? What’s up with enhanced elimination of drugs?
Sodium flux during dialysis
Renal Replacement Therapy (RRT)
Dialysis Allam Rizqallah The Palestinian Kidney Transplant Center S.A.H1/2/2005.
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
NON-TRADITIONAL RENAL REPLACEMENT THERAPY Hafez Bazaraa.
Extracorporeal techniques in poisoning Ben Creagh-Brown SHO Anaesthetics October 2003.
EDWARD WELSH MARCH Dialysis Adequacy (?).
Case Study in RRT in In Born Error of Metabolism Timothy E. Bunchman Pediatric Nephrology & Transplantation VCU School of Medicine
Elimination of Phosphate in HD and PD Reference: Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif.
Dr Umut Selda Bayrakçı Yıldırım Beyazıt University, Dept of Pediatric Nephrology, Ankara, Turkey * Basics of CRRT Terminology.
RENAL REPLACEMENT THERAPY
Drug Kinetics and CRRT: Parameters and Principles Morgan R. Cole, Pharm.D., BCPS Manager, HDVCH Pharmacy Services Clinical Pharmacy Specialist, Pediatric.
Anatomy and Physiology of Peritoneal Dialysis
Types of Dialysis  1. Hemodialysis  2. Peritoneal dialysis – just be aware of it’s existence.
Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his.
Pediatric CRRT: The Prescription
Md.Kausher ahmed Electrical department. Biomedical engineering Code:6875.
Urinary System. Secreted Substances Secreted Substances Hydroxybenzoates Hydroxybenzoates Hippurates Hippurates Neurotransmitters (dopamine) Neurotransmitters.
Dose Adjustment in Renal and Hepatic Disease
Hepatic Failure, intoxication and Hemofiltration Timothy E Bunchman Professor Pediatric Nephrology & Transplantation.
Hemodialysis and Hemofiltration in Pediatrics: An Approach to Intoxication Karen Papez MD University of Michigan Pediatric Nephrology, Dialysis & Transplantation.
Anticoagulation in CRRT
Renal Replacement Therapy (RRT) Types of therapy available to patients who have failing kidneys Debbie Jones RN CNeph(C)
Renal Replacement Therapy in Intoxications Maria Ferris, MD, MPH, PhD University of North Carolina Kidney Center Chapel Hill, North Carolina USA 7/17/2015.
Honorary Clinical Lecturer Kings College London
Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology
DIALYSIS SOLUTIONS INC.
Sustained Low Efficiency Dialysis
APPLICATION OF INDIVIDUALIZED BAYESIAN UREA KINETIC MODELING TO PEDIATRIC HEMODIALYSIS Olivera Marsenic, Athena Zuppa, Jeffrey S. Barrett, Marc Pfister.
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
PCRRT Multi-Center Registry Data Effective April 1, 2002 Multi-Center Pediatric CRRT Registry Stuart L. Goldstein, MD Assistant Professor of Pediatrics.
Progression of Chronic Kidney Disease
"Panel discussion: Inborn Errors of Metabolism – perspectives from a Nephrologist" Stefano Picca, MD Department of Nephrology and Urology, Dialysis Unit.
Dosing of Anti-Fungal agents on CRRT Timothy E. Bunchman Professor and Director Pediatric Nephrology & Transplantation Children’s Hospital of Richmond.
PCRRT Tûr'mə-nŏl'ə-jē Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
TREATMENT OF INTOXICATIONS WITH RENAL REPLACEMENT THERAPY Timothy E. Bunchman Professor Pediatric Nephrology & Transplantation.
Convection (CVVH) is Better! Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Rajeev Annigeri. Apollo Hospitals, Chennai.
CRRT TERMINOLOGY Stefano Picca, MD
BASIC PRINCIPLES OF DIALYSIS
CONTINUOUS RENAL REPLACEMENT THERAPY
HAEMODIALYSIS Shofa chasani.
Spotlight on general principles of hemodialysis
Chief Pediatric Nephrology Nemours/A.I. duPont Hospital for Children
Devices use for Neonatal AKI
Prescriptions in CRRT Timothy E Bunchman MD Professor & Director
Vascular Access and Infused Fluids for Pediatric CRRT
Pharmacokinetics & Drug Dosing
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Pediatric CRRT Terminology
Renal replacement therapy
Basics of CRRT: Terminology
SCUF Slow Continuous Ultrafiltration
Children’s Memorial Hospital Northwestern University
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
Role of r.r.t in toxicology modalities and indications
Presentation transcript:

Renal Replacement Therapy for Intoxications Timothy E. Bunchman Pediatric Nephrology & Transplantation DeVos Children’s Hospital Grand Rapids, MI (thanks to Pat Brophy for his help and some slides)

Before we get going remember Looking at therapeutic medications or intoxications there is an Looking at therapeutic medications or intoxications there is an  Absorption process &  An elimination/metabolism process

What is unique to Pediatric Intoxications? Vehicle in which the medication was delivered Vehicle in which the medication was delivered Metabolism of drug Metabolism of drug Volume of distribution Volume of distribution Variable size of the child Variable size of the child

Vehicle in which drug was administered Oral liquid/mucosal absorption Oral liquid/mucosal absorption  Rapid absorption fixed metabolism Short acting pill form Short acting pill form  Slower absorption, fix metabolism Long acting pill form Long acting pill form  Slowest absorption, fix metabolism

Drug absorption in a child

CSA metabolism varies with Age

Intoxications  2.2 million reported poisonings (1998) 67% in pediatrics67% in pediatrics Approximately 0.05% required extracorporeal eliminationApproximately 0.05% required extracorporeal elimination

Kearns, G. L. et. al. N Engl J Med 2003;349: Developmental Changes in Physiologic Factors That Influence Drug Disposition in Infants, Children, and Adolescents

DistributionRe-distribution INPUTINPUT ELIMINATION

Factors affecting clearance Delivery of drug to hemofilter Delivery of drug to hemofilter Blood flow, volume of distribution (Vd) Drugs unique ultrafiltration properties Drugs unique ultrafiltration properties Mol. Wt., Chemical structure, drug- membrane interaction, protein binding Ultrafiltration rate Ultrafiltration rate Protein binding Golper TA et al, Int J Art Organs, 1985

 Extracorporeal Methods Peritoneal DialysisPeritoneal Dialysis HemodialysisHemodialysis HemofiltrationHemofiltration Charcoal hemoperfusionCharcoal hemoperfusion –No longer needed (historical perspective) HD followed by HFHD followed by HF

INDICATIONS INDICATIONS  >48 hrs on vent  ARF  Impaired metabolism  high probability of significant morbidity/mortality  progressive clinical deterioration INDICATIONS  severe intoxication with abnormal vital signs  complications of coma  prolonged coma  intoxication with an extractable drug

PERITONEAL DIALYSIS PERITONEAL DIALYSIS  1st done in 1934 for 2 anuric patients after sublimate poisoning (Balzs et al; Wien Klin Wschr 1934;47:851 )  Allows diffusion of toxins across peritoneal membrane from mesenteric capillaries into dialysis solution within the peritoneal cavity  limited use in poisoning (clears drugs with low Mwt., Small Vd, minimal protein binding & those that are water soluble)  alcohols, NaCl intoxications, salicylates

HEMODIALYSIS HEMODIALYSIS  optimal drug characteristics for removal:  relative molecular mass < 500  water soluble  small Vd (< 1 L/Kg)  minimal plasma protein binding  single compartment kinetics  low endogenous clearance (< 4ml/Kg/min) –(Pond, SM - Med J Australia 1991; 154: )

Hemodialysis: Nl vs High Flux Normal is a smaller pore size (12 Kda) and dialysate runs at ~ 30 l/hr Normal is a smaller pore size (12 Kda) and dialysate runs at ~ 30 l/hr High flux is larger pore size (up to 50 Kda) and runs dialysate at ~ 50 l/hr High flux is larger pore size (up to 50 Kda) and runs dialysate at ~ 50 l/hr

Hemofiltration use for intoxications (primary or tandem) Hemofiltration allows for continuous therapy at bedside 24 hrs a day Hemofiltration allows for continuous therapy at bedside 24 hrs a day Can be Convective (CVVH), Diffusive (CVVHD), or combination (CVVHD) Can be Convective (CVVH), Diffusive (CVVHD), or combination (CVVHD) CVVHD does not add significantly to what can be done with maximizing CVVH or CVVHD alone CVVHD does not add significantly to what can be done with maximizing CVVH or CVVHD alone

Filtration vs. Dialysis Filtration: Clearance by convection Dependent on UFR and sieving coefficient Dialysis: Clearance by diffusion Dependent on concentration gradient

CVVH/CAVH CVVH/CAVH Convective clearance Convective clearance Replacement Solutions Replacement Solutions  Physiologic sterile solution that is either infused pre filter or post filter that infused at a set rate (Qr) CAVH/CVVH: Convective Clearance

CAVHD/CVVHD Diffusive Clearance CVVHD/CAVHD CVVHD/CAVHD Diffusive clearance Diffusive clearance Dialysate Dialysate  Physiologic sterile solution that is infused countercurrent to the blood flow rate (Qd)

Sieving Coefficients Solute (MW)Convective Coefficient Diffusion Coefficient Urea (60)1.01 ± ± 0.07 Creatinine (113)1.00 ± ± 0.06 Uric Acid (168)1.01 ± ± 0.04* Vancomycin (1448)0.84 ± ± 0.04** Cytokines (large)adsorbedminimal clearance *P<0.05 **P<0.01

Dialysis Dose Weekly stdKt/V eKt/V each dialysis No. of Days/weekEDD 35ml/kg45ml/kg20ml/kg Adapted from Gotch et al. Kidney Int 2000;58:S3-18 CRRT PD

So for any clearance moment to moment High (flux) efficiency HD > standard HD > CVVH > CVVHD > PD High (flux) efficiency HD > standard HD > CVVH > CVVHD > PD Thought process of acute RRT needs to ensure that pt does not become hypophosphatemic, hypokalemic, etc Thought process of acute RRT needs to ensure that pt does not become hypophosphatemic, hypokalemic, etc  Electrolyte components can be added to the dialysate “bath”

Intoxicants amenable to Hemodialysis Intoxicants amenable to Hemodialysis  alcohols  ethylene glycol  Methanol (beware that one does not clear the rescue drug)(beware that one does not clear the rescue drug)  vancomycin (high flux)  Highly protein bound seizure drugs  lithium  salicylates

A good Friday night Teens deciding that beer was to expensive so they went for anti-freeze instead Teens deciding that beer was to expensive so they went for anti-freeze instead Had metabolic acidosis and osmolar gap Had metabolic acidosis and osmolar gap Before use of (fomepizol) treated with IV alcohol and dialysis (may clear rescue drug) Before use of (fomepizol) treated with IV alcohol and dialysis (may clear rescue drug) Alcohols are in general small molecular wt poorly protein bound Alcohols are in general small molecular wt poorly protein bound

Ethylene Glycol Intoxication Rx with (std) Hemodialysis Duration of Rx (hrs) Mg/ml (> 30 mg/ml toxic)

A bad Friday night If a little vancomycin is good a lot is better If a little vancomycin is good a lot is better Historically thought to be poorly dialyzable but with High efficient membrane clears easily Historically thought to be poorly dialyzable but with High efficient membrane clears easily Senario is in children with reduction in GFR dosed based upon nl GFR Senario is in children with reduction in GFR dosed based upon nl GFR Has a 2 compartment distribution Has a 2 compartment distribution

Vancomycin clearance High efficiency dialysis membrane Time of therapy Vanc level (mic/dl) Rx Rebound

A fun Friday night Highly protein bound anti-seizure meds thought to be only cleared by CHP Highly protein bound anti-seizure meds thought to be only cleared by CHP CHP is where one removes blood from the pt, filters thru a charcoal filter, goes to a dialysate membrane back to the pt CHP is where one removes blood from the pt, filters thru a charcoal filter, goes to a dialysate membrane back to the pt Problem with CHP, large extracorporeal circuit, cold, hypocalcemic, coagulopathic.. Problem with CHP, large extracorporeal circuit, cold, hypocalcemic, coagulopathic.. essentially “they get ugly” essentially “they get ugly”

High flux hemodialysis for Tegretol Intoxication HD Rx Hrs from time of ingestion Mic/ml 2 compartment rebound

Tandem therapies: prevention of the rebound If one has a rapid generation rate or a large volume of distribution consider tandem therapies If one has a rapid generation rate or a large volume of distribution consider tandem therapies HD for rapid removal followed by HF for prevention of the rebound HD for rapid removal followed by HF for prevention of the rebound

HD Rx of Hyperammonemia ( Gregory et al, Vol. 5,abst. 55P,1994: ) NH 4 micromoles/l Time (Hrs) NH4 rebound with reinstitution of HD

HD to CRRT (prevention of the rebound) Time (Hrs) NH 4 micromoles/L Transition from HD to CVVHD

Tandem Therapies HD to HF Hours LimEq/LLimEq/L CVVHD following HD for Lithium poisoning HD started CVVHD started CT-190 (HD) Multiflo-60 both patients BFR-pt #1 200 ml/min HD & CVVHD -pt # ml/min HD & 200 ml/min CVVHD PO 4 Based dialysate at 2L/1.73m 2 /hr Li Therapeutic range mEq/L

Summary RRT can be an adjunct to normal elimination of drug or a substitution of drug removal (with concomitant ARF) RRT can be an adjunct to normal elimination of drug or a substitution of drug removal (with concomitant ARF) RRT therapies are safe RRT therapies are safe RRT machines are “pediatric friendly” RRT machines are “pediatric friendly” HF HD > HF > CVVH > CVVHD HF HD > HF > CVVH > CVVHD No role for PD No role for PD

Summary Tandem therapies allow for rapid and sustaining removal of drugs with prevention of rebound… Tandem therapies allow for rapid and sustaining removal of drugs with prevention of rebound… Vascular access already in place Vascular access already in place Early consideration of RRT Early consideration of RRT

Conclusion ……..if you can measure it, we can clear it…